Search
Close this search box.

Well-Defined Heparin Mimetics Can Inhibit Binding of the Trimeric Spike of SARS-CoV‑2 in a Length-Dependent Manner

Author(s)

L. Sun, P. Chopra, I. Tomris, R. van der Woude, L. Liu, R. P. de Vries & G-J. Boons

Sources

JACS Au (2023) https://doi.org/10.1021/jacsau.3c00042

SARS-CoV-2 employs heparan sulfate (HS) as an initial cellular attachment factor, and therefore, there is interest in developing heparin as a therapeutic for SARS-CoV-2. The authors describe the preparation of well-defined heparin mimetics by a controlled head-to-tail assembly of Heparan Sulfate oligosaccharides having an alkyne or azide moiety by copper-catalyzed azide-alkyne cycloaddition (CuAAC). Alkyne- and azide-containing sulfated oligosaccharides were prepared from a common precursor by modifying an anomeric linker with 4-pentynoic acid and by enzymatic extension with an N-acetylglucosamine having an azide moiety at C-6 (GlcNAc6N3), respectively, followed by CuAAC. The process of enzymatic extension with GlcNAc6N3 followed by CuAAC with the desired alkyne-containing oligosaccharides could be repeated to give compounds composed of 20 and 27 monosaccharides, respectively.
896.png
The heparin mimetics could inhibit the SARS-CoV-2 spike or RBD binding to immobilized heparin or to Vero E6 cells. The inhibitory potency increased with increasing chain length, and a compound composed of four sulfated hexasaccharides linked by triazoles had a similar potency as unfractionated heparin. Sequence analysis and HS microarray binding studies with a wide range of RBDs of variants of concern indicate that they have maintained HS-binding capabilities and selectivities. The heparin mimetics exhibit no or reduced binding to antithrombin-III and platelet factor 4, respectively, associated with side effects.

Latest news

Plastic production reached 400 million tons in 2022, with packaging and single-use plastics accounting for...

Glycans constitute the most complicated post-translational modification, modulating protein activity in health and disease. However,...

The introduction of AlphaFold 2 has sparked a revolution in the modelling of protein structure...

Understanding how carbohydrates regulate proteins in physiological and pathological processes provides opportunities to address key...